Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease
Heba M. Mansour, Hala M. Fawzy, Aiman S. El‐Khatib, et al.
Experimental Neurology (2021) Vol. 341, pp. 113697-113697
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Challenges and hopes for Alzheimer’s disease
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 201
EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
Hee-Jeong Choi, Yoo Joo Jeong, Ji‐Eun Kim, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
Drugs repurposing in the experimental models of Alzheimer’s disease
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access | Times Cited: 1
EGF receptor in organ development, tissue homeostasis and regeneration
Claudia Tito, Silvia Masciarelli, Gianni Colotti, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer’s Disease: Current Perspectives and Challenging Prospects
Heba M. Mansour, Hala M. Fawzy, Aiman S. El‐Khatib, et al.
Neuroscience (2021) Vol. 469, pp. 191-196
Closed Access | Times Cited: 47
Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer’s disease
Pavan K. Jayaswamy, M. Vijaykrishnaraj, Prakash Patil, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101791-101791
Closed Access | Times Cited: 32
Kinases control of regulated cell death revealing druggable targets for Parkinson’s disease
Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El‐Khatib, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101841-101841
Closed Access | Times Cited: 21
Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer’s disease
Mahmoud Nabawy Mahmoud Khattab, Heba M. Mansour, HalaM Fawzy, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 9, pp. 1913-1913
Open Access | Times Cited: 40
Single-cell-led drug repurposing for Alzheimer’s disease
Silvia Parolo, Federica Mariotti, Pranami Bora, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease
Heba M. Mansour, Ahmed F. Mohamed, Mahmoud M. Khattab, et al.
European Journal of Pharmacology (2023) Vol. 954, pp. 175875-175875
Closed Access | Times Cited: 14
Repositioning of baricitinib for management of memory impairment in ovariectomized/D-galactose treated rats: A potential role of JAK2/STAT3-PI3K/AKT/mTOR signaling pathway
Merhan O. Hindam, Lamiaa A. Ahmed, Nesrine S. El Sayed, et al.
Life Sciences (2024) Vol. 351, pp. 122838-122838
Closed Access | Times Cited: 6
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein
Heba M. Mansour, Aiman S. El‐Khatib
Ageing Research Reviews (2023) Vol. 92, pp. 102114-102114
Closed Access | Times Cited: 11
Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Zhuo Jun Shen, Yun Bo Fu, Jin Ling Hou, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 18
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
Austin Lui, Jordan Vanleuven, David Perekopskiy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1546-1546
Open Access | Times Cited: 17
Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides
Heba M. Mansour, Aiman S. El‐Khatib
European Journal of Pharmacology (2025), pp. 177529-177529
Closed Access
A common molecular and cellular pathway in developing Alzheimer and cancer
Mohammad Ali, Shahid Ud Din Wani, Tathagata Dey, et al.
Biochemistry and Biophysics Reports (2023) Vol. 37, pp. 101625-101625
Open Access | Times Cited: 8
The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic
Heba M. Mansour
Ageing Research Reviews (2024) Vol. 94, pp. 102195-102195
Closed Access | Times Cited: 2
Study on the active components and mechanism of Suanzaoren decoction in improving cognitive impairment caused by sleep deprivation
Li Cheng, Fei Wang, Ziheng Li, et al.
Journal of Ethnopharmacology (2022) Vol. 296, pp. 115502-115502
Closed Access | Times Cited: 10
Repositioning of receptor tyrosine kinase inhibitors
Heba M. Mansour, Aiman S. El‐Khatib
Elsevier eBooks (2023), pp. 353-401
Closed Access | Times Cited: 6
Receptor tyrosine kinases
Chinna Babu Pulivarthi, Shruti Shikha Choubey, Shivam Kumar Pandey, et al.
Elsevier eBooks (2023), pp. 45-77
Closed Access | Times Cited: 5
Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor
Heba M. Mansour, Ahmed F. Mohamed, Mahmoud M. Khattab, et al.
Brain Research (2024) Vol. 1834, pp. 148893-148893
Closed Access | Times Cited: 1
Genome-Wide Mendelian Randomization Identifies Ferroptosis-Related Drug Targets for Alzheimer’s Disease
Ying Wang, Xinhua Song, Rui Wang, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 1185-1197
Open Access | Times Cited: 1
Antioxidant and neuro-modulatory effects of niacin prevent D-galactose-induced behavioral deficits and memory impairment
Noreen Samad, Ayesha Hameed, Natasha Manzoor, et al.
Experimental Gerontology (2024) Vol. 198, pp. 112624-112624
Open Access | Times Cited: 1
Nutrition and Psychiatric Disorders: Focus on Schizophrenia
Heba M. Mansour
(2022), pp. 313-368
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top